Table 2 Relative abundance (%) of EGF peptides containing putative binding sites to the agarose carrier, obtained by LC–ESI–MS/MS analysis.

From: Design of epidermal growth factor immobilization on 3D biocompatible scaffolds to promote tissue repair and regeneration

Residue

Soluble EGF (%)

Glyoxyl-EGF7 (%)

CNBr-EGF (%)

Glyoxyl-EGF10 (%)

M1 (N-terminal)

23.5

K29

27.7

35.7

69.8

100

K49

48.8

64.3

30.2